Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

ImmuLogic restructures its operations

Nov. 26, 1997

Role of complement in mast cell-dependent natural immunity

Nov. 24, 1997

Topical FK-506 for skin allograft rejection

Nov. 21, 1997

New cytokine production inhibitors revealed by SS Pharm.

Nov. 21, 1997

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

BCH-1393 stimulates CTL response in vitro and in vivo

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Immunological method for preventing ALL in children available for licensing

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...